Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
58
MNMD Quote, Financials, Valuation and Earnings
Last price:
$14.70
Seasonality move
:
25.87%
Day range:
$13.52 - $14.16
52-week range:
$4.70 - $14.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.58x
Volume:
1.9M
Avg. volume:
1.9M
1-year change:
73%
Market cap:
$1.4B
Revenue:
--
EPS (TTM):
-$1.97
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
-- | -$0.52 | -- | -26.44% | $28.67 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -9.65% | -37.91% | $12.3077 |
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.04% | -- | $36.00 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 272.5% | -33.67% | $2.20 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
$14.03 | $28.67 | $1.4B | -- | $0.00 | 0% | -- |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8700 | $12.3077 | $213.4M | -- | $0.00 | 0% | 194.60x |
|
ELMD
Electromed, Inc.
|
$29.40 | $36.00 | $245.2M | 31.63x | $0.00 | 0% | 3.92x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.91 | $14.20 | $181.2M | 34.07x | $0.00 | 0% | 1.34x |
|
VNRX
VolitionRX Ltd.
|
$0.29 | $2.20 | $35.1M | -- | $0.00 | 0% | 19.58x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.72 | $1.50 | $100.8M | 70.59x | $0.00 | 0% | 0.79x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
23.62% | 2.048 | 4.46% | 3.20x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
ELMD
Electromed, Inc.
|
-- | 1.105 | -- | 4.58x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
-- | -$45.7M | -70.5% | -80.63% | -- | -$29.8M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Mind Medicine (MindMed), Inc. vs. Competitors
-
Which has Higher Returns MNMD or CATX?
Perspective Therapeutics, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of -12425.36%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About MNMD or CATX?
Mind Medicine (MindMed), Inc. has a consensus price target of $28.67, signalling upside risk potential of 104.32%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 328.84%. Given that Perspective Therapeutics, Inc. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.10 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is MNMD or CATX More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.610, which suggesting that the stock is 160.96% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock MNMD or CATX?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or CATX?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Perspective Therapeutics, Inc. quarterly revenues of $209K. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 194.60x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M CATXPerspective Therapeutics, Inc.194.60x -- $209K -$26M
-
Which has Higher Returns MNMD or ELMD?
Electromed, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of 12.65%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About MNMD or ELMD?
Mind Medicine (MindMed), Inc. has a consensus price target of $28.67, signalling upside risk potential of 104.32%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 22.45%. Given that Mind Medicine (MindMed), Inc. has higher upside potential than Electromed, Inc., analysts believe Mind Medicine (MindMed), Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.10 0 0 ELMDElectromed, Inc.4 0 0 -
Is MNMD or ELMD More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.610, which suggesting that the stock is 160.96% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.266, suggesting its less volatile than the S&P 500 by 73.442%.
-
Which is a Better Dividend Stock MNMD or ELMD?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or ELMD?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 31.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 3.92x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M ELMDElectromed, Inc.3.92x 31.63x $16.9M $2.1M
-
Which has Higher Returns MNMD or INFU?
InfuSystem Holdings, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of 6.19%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About MNMD or INFU?
Mind Medicine (MindMed), Inc. has a consensus price target of $28.67, signalling upside risk potential of 104.32%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 59.37%. Given that Mind Medicine (MindMed), Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Mind Medicine (MindMed), Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.10 0 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is MNMD or INFU More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.610, which suggesting that the stock is 160.96% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock MNMD or INFU?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or INFU?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 34.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 1.34x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M INFUInfuSystem Holdings, Inc.1.34x 34.07x $36.5M $2.3M
-
Which has Higher Returns MNMD or VNRX?
VolitionRX Ltd. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of -862.39%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About MNMD or VNRX?
Mind Medicine (MindMed), Inc. has a consensus price target of $28.67, signalling upside risk potential of 104.32%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 670.04%. Given that VolitionRX Ltd. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe VolitionRX Ltd. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.10 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is MNMD or VNRX More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.610, which suggesting that the stock is 160.96% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock MNMD or VNRX?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or VNRX?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 19.58x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M VNRXVolitionRX Ltd.19.58x -- $627.3K -$5.4M
-
Which has Higher Returns MNMD or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of 3.93%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About MNMD or XTNT?
Mind Medicine (MindMed), Inc. has a consensus price target of $28.67, signalling upside risk potential of 104.32%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 108.33%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.10 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is MNMD or XTNT More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.610, which suggesting that the stock is 160.96% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.
-
Which is a Better Dividend Stock MNMD or XTNT?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or XTNT?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 70.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 0.79x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M XTNTXtant Medical Holdings, Inc.0.79x 70.59x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
70
RGC alert for Jan 8
Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.
Buy
64
RVMD alert for Jan 8
Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.
Sell
38
CRNX alert for Jan 8
Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.
